Slater Hurst

Managing Director

Slater supports biopharma and biotech companies in their business development and commercialization strategy. He partners with companies focused on commercial assessments, business development and new product planning strategy, pipeline/portfolio prioritization and strategy, and launch roadmap planning, bringing deep experience in rare diseases. Clients leverage Slater’s insights in navigating early- to mid- clinical stage product development opportunities and the commercial needs required to recognize their full potential.

Prior to joining ClearView, Slater spent several years working in a translational hematology/oncology research lab in the Boston area. Slater holds a B.A. from Duke University and a M.S. from Boston University.